Horizon Pharma swoops in on Raptor
Horizon Pharmaceuticals plc (HZNP) continued its M&A maneuvering on Monday with an $800 million agreement to buy Raptor Pharmaceutical Corp. (RPTP) to expand its rare disease business and extend its international presence.
The Dublin company said it would offer $9 a share for Novato, Calif.-based Raptor. That's almost 21% above Raptor's most recent price of $7.45 before trading in the shares was suspended.
Horizon bought Crealta Holdings LLC for $510 million in...